Bottom Line As of May 2026: BPC-157 is not formally approved for routine 503A compounding TB-500 is not formally approved for routine 503A compounding Injectable GHK-Cu remains in a gray regulatory area FDA advisory committee meetings are scheduled that could significantly influence future policy Political announcements do not equal FDA approval Many clinics and pharmacies are still operating in a legally uncertain environment This situation may continue to evolve quickly over the next 1218 months
Vitamin C also plays a huge role in healing and immune function
Both peptides remain on the WADA Prohibited List under growth factors and growth factor modulators, which affects athlete eligibility separately from criminal law [unverified]
BAC water = multi-dose, 0.9% benzyl alcohol preservative
They made advanced procedures accessible
[3] Side effects [edit] Some side effects for peptide hormones and analogues are motor paralysis, diabetes mellitus, hypothyroidism, headaches, vomiting, thrombosis, osteoporosis, and cancer